Adoptive transfer of CD4 + CD25
CD25
+ regulatory T cells has been shown to have therapeutic effects in experimental graft-vshost disease (GVHD) models. Chemokines play an important role in the recruitment of alloreactive donor T cells into target organs during GVHD. In this study, we investigated the effectiveness of targeted delivery of CD4 +
+ regulatory T cells via a transfected chemokine receptor on reduction of organ damage during acute GVHD. High levels of expression of Th1-associated chemokines (CXCL9, CXCL10 and CXCL11) and their receptor CXCR3 were observed in the liver, lung and intestine of GVHD-induced recipient mice. Recipient mice that had undergone transfer of CD4 
Introduction
Despite improvements in allogeneic bone marrow transplantation (BMT), graft-vs-host disease (GVHD) remains a significant problem after transplantation. 1, 2 GVHD is initiated when donor T cells recognize minor or major antigens presented by host major histocompatibility complex (MHC) molecules. This recognition leads to elaboration of cytokines such as tumor necrosis factor (TNF)-a and interleukin (IL)-1 and the destruction of recipient antigen-presenting cells (APCs) and other cells by these cytokines, and also cytolytic proteins such as perforin, granzyme and Fas/FasL, as well as reactive oxygen species. Before tissue destruction, alloreactive donor T cells must be recruited to specific organs in which GVHD occurs, such as the liver, lung, intestine and skin. Chemokines upregulated in target organs and their receptors expressed on infiltrating donor T cells play an important role in this recruitment. 3 Expression of several chemokines in target organs during GVHD has been demonstrated in a number of experimental models. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Published data on the role of chemokines in GVHD are somewhat conflicting, since upregulation of chemokines in target organs during GVHD is influenced by transplant conditioning and recipient strain. 16, 17 In conditioned murine GVHD models, the expression of chemokines such as CCL2, CXCL9, CXCL10 and CXCL11 is upregulated in the liver early after GVHD induction. 6, 8, 15 On the other hand, significant expression of chemokines including CCL2, CCL3, CCL4, CCL5, CCL11, CXCL9, CXCL10 and CXCL11 has been demonstrated in the intestine and lung early after GVHD induction. 5, 7, 16, 17 In addition, expression of CXCR3 and CCR5, the receptors for Th1-associated chemokines (CXCL9, CXCL10 and CXCL11) and CCL3, CCL4 and CCL5, respectively, also increases significantly in the liver, lung and intestine during acute GVHD. 11, 13, 16 These findings suggest that in addition to CCR5 and its ligands, Th1-associated chemokines and their receptor CXCR3 are also associated with infiltration of donor T cells into target organs such as the liver, lung and intestine in conditioned GVHD. CD4 + CD25 + regulatory T cells are critical for the regulation of host tolerance and are considered to have enormous potential for suppressing pathological immune responses in autoimmune disease, transplantation and GVHD. 18, 19 These cells express a specific transcription factor, forkhead box p3 (Foxp3), which has been associated with their development and suppressive function. [20] [21] [22] The mechanism by which CD4 + CD25 + regulatory T cells suppress immune responses is poorly understood, but these cells appear to suppress a variety of reactions, including CD4 + and CD8 + T-cell as well as B-cell responses in a cell contact-dependent fashion. 23 
CD25
+ regulatory T cells is not therapeutically practical, and it is critically important to expand the number of CD4 + CD25 + regulatory T cells. Furthermore, to reduce the possibility of undesirable effects such as infection and tumor development, it is also important that the numbers of transferred regulatory T cells are small and work in a local and specific manner. Accordingly, we have devised a chemokinereceptor system to accumulate CD4 +
+ regulatory T cells efficiently in target organs.
In the present study, we prepared CD4 + CD25 + regulatory T cells in which the receptor for Th1-associated chemokines (CXCL9 to 11), CXCR3, was highly expressed. We then characterized the CXCR3-expressing Foxp3 + regulatory T cells and their therapeutic effect on liver, lung and intestine injury by accumulating them in target organs in a conditioned murine acute GVHD model.
Results
Expression of Th1-associated chemokines and their receptor CXCR3 in the liver, intestine and lung during acute GVHD Previous studies have suggested that T-cell polarization affects organ tropism of GVHD and that the chemokine receptor CXCR3 plays an important role in the migration of effector T cells into target organs such as the liver and intestine. 11 However, chemokine expression in target organs is influenced by transplant conditioning and recipient strain. 16, 17 In this study, we focused on the liver, intestine and lung as target organs of acute GVHD and examined the expression of the ligands for CXCR3, CXCL9, CXCL10 and CXCL11 in these organs during acute GVHD. Haploidentical parent-to-F1 transplants were performed, in which lethally irradiated B6D2F1 mice were given 5 Â 10 6 T cell-depleted bone marrow (BM) cells supplemented with 2 Â 10 6 splenic T cells from C57BL/6 (GVHD-induced mice) or syngeneic mice (BMT control mice). Histopathology on day 3 was unremarkable in both groups, with the exception of typical postirradiation features in the intestines. In the GVHDinduced mice, histological analysis revealed lymphocyte infiltration on day 5 post-BMT in the liver, lung and intestine. As shown in Figures 1a and b , a positive correlation between the mRNA levels and protein levels of chemokines was found. Consequently, Th1-associated chemokines (CXCL9, CXCL10 and CXCL11) were increased significantly 1 week after GVHD induction, and the expression levels of these chemokines in the liver, intestine and lung of GVHD-induced mice at 1 week post-BMT were significantly higher than those in BMT control mice. Furthermore, CXCR3 receptor expression in the liver, intestine and lung of GVHD-induced mice was increased significantly from 1 to 3 weeks post-BMT in comparison with BMT control mice (Figure 1c) . From these findings, we confirmed that high levels of expression of Th1-associated chemokines and their receptor CXCR3 were present in the liver, intestine and lung of these GVHD-induced mice at 1 week post-BMT. The protein levels of Th1-associated chemokines in the liver, intestine and lung during acute GVHD. An ELISA for assaying CXCL9, CXCL10 and CXCL11 was performed on supernatants from the tissue homogenates of the above samples. Statistical analysis was performed using Student's t-test (*Po0.05 vs control). To determine the specific pathological changes by GVHD in target organs, we carried out histopathological analysis of liver, intestine and lung tissue sections at 4 weeks after injection of regulatory T cells in all groups. As shown in Figure 4 , the recipients that had undergone transfer of 4 Â 10 5 nTreg or Treg cells showed no significant reduction of the histopathological GVHD score for the liver, intestine and lung compared with GVHD-induced mice. The recipients that had undergone transfer of 1 Â 10 6 CXCR3-Treg cells showed a significantly reduced (Po0.05) histopathological GVHD score for the liver, intestine and lung compared with Treg cell-transferred recipients (liver, 1 6 CXCR3-Treg cells showed significant amelioration of GVHD changes clinically and histopathologically. These findings suggest that CXCR3-Treg cells migrate efficiently into Th1-associated chemokineexpressing target organs, and show local suppressive activity in a dose-dependent manner. On the other hand, there was no significant difference between Treg and CXCR3-Treg cell accumulation in the spleen at 4 weeks after injection of 1 Â 10 6 cells although Treg cell accumulation was slightly higher compared with CXCR3-Treg cells (number of cells per organ, 49 900716 900 vs 44 40079800, respectively).
Characterization of Treg cells and CXCR3-Treg cells

Localization of adoptively transferred Treg cells and CXCR3-Treg cells in the liver, intestine and lung of recipient mice
Next, to compare the migration of Treg cells and CXCR3-Treg cells in the liver, intestine and lung, we examined Foxp3 expression in each group by qRT-PCR and analyzed the mononuclear cells isolated from the livers, intestines and lungs in each group by immunofluorescence. As shown in Figure 5 , the localization of CXCR3-Treg cells to the liver was increased 418-fold and 410-fold at 24 h and 7 days after transfer by qRT-PCR, respectively, compared with that of Treg cells, and the regional localization continued to increase until 28 days post-BMT. The kinetics of cell localization in the intestine and lung showed a similar pattern to those in the liver. On the other hand, the number of CD8 + T cells localized in the liver, intestine and lung of CXCR3-Treg celltransferred recipients was significantly lower (Po0.05) than that of Treg cell-transferred recipients (cell number per 100 mg tissue at 28 days after injection of 1 Â 10 6 regulatory T cells: liver, 21 00071700 vs 49 00075300; intestine, 10 70072100 vs 20 00076200 and lung, 
Discussion
In the present study using a murine model, we demonstrated the potential of a new therapeutic approach for acute GVHD through the efficient accumulation of chemokine receptor-expressing CD4 + CD25 + regulatory T cells in target organs. Our main findings were as follows: (1) high levels of expression of Th1-associated chemokines (CXCL9, CXCL10 and CXCL11) and their receptor CXCR3 were observed in the liver, intestine and lung of GVHD-induced recipient mice; (2) both Treg and CXCR3-Treg cells had almost the same suppressive properties; (3) CXCL10-directed chemotactic activity of CXCR3-Treg cells was much higher than that of Treg cells; (4) recipient mice that had undergone transfer of CXCR3-Treg cells showed significant amelioration of GVHD changes in the liver, intestine and lung in comparison with Treg cell-transferred recipient mice and (5) this effect was due to migration of higher numbers of CXCR3-Treg cells into Th1-associated chemokine-expressing target organs, and their localization there for a longer time, resulting in stronger suppressive activity. Three phases have been described in the development of acute GVHD. 1, 2 In the conditioning phase, host tissues are damaged by the pretransplantation conditioning regimen. Conditioning regimens upregulate adhesion molecules and inflammatory mediators, including IL-1 and TNF-a, which enhance the expression of MHC and costimulatory molecules by tissue APCs. In the activation phase, donor CD4 + and CD8 + T cells interact with host APCs, leading to activation and differentiation toward a T helper 1-T cytotoxic 1 (Th1/Tc1) effector pathway, and migration of these cells to target organs affected during acute GVHD. The effector phase involves target organ damage by cytolytic effector mechanisms, such as TNF-a, perforin, granzyme, Fas/FasL and reactive oxygen species.
nTreg cells, which show high expression of Foxp3, are essential for the maintenance of peripheral tolerance. 18, 19 nTreg cells are not suppressive and require TCR interaction with a specific antigen or polyclonal stimulus to exert suppression. However, once activated, they are able to suppress the proliferation and activation of CD4 + and CD8 + T cells. The suppressive function of CD4 + CD25
+ regulatory T cells is generally considered to be cell contact-dependent and cytokine independent. Recently, the role of Foxp3 in function and differentiation of regulatory T cells has been reported. [39] [40] [41] [42] The nuclear transcription factor Foxp3 is selectively expressed in regulatory T cells and is required for development and function of regulatory T cells. Foxp3 can induce a phenotype of regulatory T cells in conventional CD4 + CD25
À T cells. In contrast, regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Foxp3 works directly following binding the forkhead motif or interacting with NFAT, or indirectly through inducing regulatory MiR-155 or other genes, leading to regulatory function and differentiation. However, the molecular nature of the contact-dependent interaction has not been fully established. Therefore, in order for CD4 + CD25 + regulatory T cells to function efficiently, it is necessary to accumulate them in target organs.
There is contradictory information about the chemotactic activity of CD4 + CD25 + regulatory T cells. These cells have been reported to express CCR4, CCR5, CCR7 and CCR8, and to be chemoattracted by their respective ligands, CCL22, CCL4, CCL19 and CCL1. [43] [44] [45] [46] However, Gavin et al. 47 showed that CD4 + CD25 + regulatory T cells were refractory to lymphoid chemokines such as CCL2, CCL4, CCL19, CCL21, CCL22 and CXCL12. These discrepancies among the various reports may be because of small variations in the experimental protocol or mouse strains used, but a more important reason may be that Figure 4 Histopathological graft-vs-host disease (GVHD) evaluation of target organs in nTreg cell-, Treg cell-and CXCR3-Treg celltransferred recipient mice. Histopathological analysis of the tissue sections was performed at 4 weeks after injection of regulatory T cells in all groups. The severity of GVHD was assessed by histopathological analysis of liver, intestine and lung using a semiquantitative scoring system as described in the 'Materials and methods' section. Nontransferred GVHD-induced B6D2F1 recipient mice were used as control. Values are the mean and SD (n ¼ 6-8 mice per group). Similar results were observed in two independent experiments. Statistical analysis was performed using Student's t-test (*Po0.05 vs control. **Po0.05 vs 4 Â 10 5 Treg. ***Po0.05 vs 1 Â 10 6 Treg).
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distinct cell subsets have unique chemokine responses, and most of the previous studies did not examine these subsets. In the present study, cultured Treg cells had very low, CXCL10-directed chemotactic activity, whereas CXCR3-Treg cells exhibited marked CXCL10-directed chemotaxis.
The involvement of chemokines in the recruitment of effector T cells to target organs during GVHD has also been reported in a number of experimental models. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Several chemokines such as CCL2, CCL3, CCL4, CCL5, CCL11, CXCL9, CXCL10 and CXCL11, are expressed in the liver, intestine and lung during experimental GVHD. Studies using conditioned murine GVHD models have demonstrated a consistent pattern in the kinetics of expression of these chemokines. Chemokines, including CCL2, CXCL9, CXCL10 and CXCL11 are expressed early after transplantation. 8 Expression of CCL3 occurred later compared with the expression of CXCL9, CXCL10 and CXCL11, and was shown to be dependent on expression by infiltrating donor T cells. 4, 5, 16 Chemokine receptor CXCR3 expressed on donor T cells has been reported to play an important role in intestinal infiltration during GVHD in a conditioned GVHD model. 11 The recipient mice that received CXCR3 À/À donor T cells demonstrated diminished intestine and liver damage. Duffner et al.
explained this finding by suggesting that accumulation of CD8 + T cells in the target organs of BMT recipients from CXCR3
À/À donors was significantly lower than that from wild-type donors. In contrast, Mapara et al. 17 have reported that the severity of GVHD was not significantly different between recipients of CXCR3 +/+ or CXCR3 À/À splenocytes. Although the reason for this discrepancy is unknown, the latter phenomenon may have occurred because accumulation of regulatory T cells in the target organs may be not significantly different between recipients of CXCR3 +/+ or CXCR3 À/À splenocytes since CXCR3 expression of regulatory T cells is low. From these findings and our present results, Th1-associated chemokines and their receptor CXCR3 seem to play an important role in infiltration of donor effector T cells including CD8 + T cells into the liver, intestine and lung during acute GVHD, especially at an early stage after GVHD induction, in conditioned murine GVHD models.
The expression of CD62L and CCR5 on donor regulatory T cells has been reported to play an important role in suppressing GVHD changes in the target 36 This correlated with reduced accumulation of CCR5 À/À as compared with wild-type regulatory T cells in the target organs more than 1 week after BMT. These findings indicate that in addition to their role in inhibiting effector T-cell expansion in lymphoid tissues during the first week after GVHD induction, later recruitment of regulatory T cells to lymphoid tissues and target organs is important in their ability to prolong survival after BMT.
On the basis of these results, we investigated whether organ damage during acute + regulatory T cells has been shown to exert potentially therapeutic effects on acute GVHD in many animal models. [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] However, the numbers of transferred CD4 + CD25 + regulatory T cells are small, and work in a local and specific manner, since these cells suppress the immune response to tumors and infections. Recipient-specific alloreactive regulatory T cells, which were obtained in culture by stimulating the cells with allogeneic irradiated APCs and IL-2, have been reported to be more activated and expanded in target organs and draining lymph nodes, resulting in more pronounced prevention of GVHD, compared with naturally occurring or cultured polyclonal CD4 + CD25 + regulatory T cells. 31, 33, 38 Therefore, CXCR3-expressing recipient-specific alloreactive regulatory T cells, rather than CXCR3-expressing cultured polyclonal CD4 + CD25 + regulatory T cells, may ameliorate organ damage more efficiently. Although some problems such as the most effective vector for use in humans remain unresolved, our method may have potentially useful applications for treatment of organ damage in humans with acute GVHD.
Materials and methods
Mice and cells
were purchased from Charles River Japan Inc. (Yokohama, Japan). This study was approved by the Animal Ethics Committee, Ehime University. The age of mice used for experiments ranged between 10 and 14 weeks. Mice were housed in sterilized microisolator cages and received filtered water and normal chow or autoclaved drinking water for the post-BMT. The packaging cell line, PLAT-E, was kindly provided by Prof. T Kitamura, Institute of Medical Science, University of Tokyo, Tokyo, Japan. PLAT-E cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum (FCS; Life Technologies, Gaithersburg, MD, USA).
Antibodies and reagents
Mouse CXCL10, IL-2 and the rat anti-mouse CXCR3 monoclonal antibody (MoAb) (220803) were obtained from R&D Systems (Minneapolis, MN, USA) . The hamster anti-mouse CD3e MoAb (145-2C11) and fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse CD8a MoAb (53-6.7), peridinin chlorophyll-a protein (PerCP)-conjugated streptavidin and biotin-conjugated goat anti-rat Ig-specific polyclonal antibody were purchased from BD Biosciences (San Diego, CA, USA). The rat anti-mouse Foxp3 MoAb (FJK-16s) was obtained from eBioscience (San Diego, CA, USA).
BMT and GVHD induction
Mice were transplanted according to a standard protocol described by Hill et al. 48 Briefly, recipients (B6D2F1) received 13 Gy total body irradiation, split into two doses separated by 3 h to minimize gastrointestinal toxicity. Donor BM (C57BL/6) was removed aseptically from femurs and depleted T cells with anti-mouse Thy 1.2 MoAb (Cedar Lane Laboratories, Hornby, Ontario, Canada) and Low-Tox-M rabbit complement (Cedar Lane Laboratories). Splenic T cells were prepared by purification over nylon wool for GVHD induction. T celldepleted BM cells (5 Â 10 6 ) plus 2 Â 10 6 splenic T cells from allogeneic (C57BL/6 for GVHD induction) or syngeneic (B6D2F1 for control) donors were resuspended in 0.2 ml of RPMI1640 medium (Life Technologies) and injected intravenously into recipients on day 0. Survival was monitored daily, and recipients body weights and clinical GVHD scores were measured twice weekly. The recipients were observed for 5 weeks.
Assessment of GVHD
The severity of GVHD was assessed with a clinical GVHD scoring system as described by Cooke et al. 49 Briefly, ear-tagged animals in coded cages were individually scored twice weekly for five clinical parameters on a scale from 0 to 2: weight loss (grade 1, 10-25%; grade 2, 425%), posture (1, kyphosis only at rest; 2, severe kyphosis impairs movement), activity (1, stationary 450% of the time; 2, stationary unless stimulated), fur (1, ventral and/or slight back ruffling; 2, ruffling entire body) and skin (1, erythema or scaling paws/tail/ anus, ear shriveling; 2, multiple open lesions). A clinical GVHD score was generated by summation of the five criteria scores (0-10).
Histopathological analysis
Tissues were fixed in 10% formalin, then paraffin sections were prepared and stained with hematoxylin and eosin. Slides were examined in a blinded fashion by one individual using a semiquantitative scoring system. A semiquantitative scoring system was used to assess the following histopathological manifestations known to be associated with GVHD:
50 liver: portal tract expansion by In vitro expansion of CD4 + CD25 + T cells
The CD4 + CD25 + T cells were purified from spleen cells of donor C57BL/6 mice using a CD4 + CD25 + regulatory T cell isolation kit (Miltenyi Biotec, GmbH, Germany), according to the manufacturer's recommendation. The purity of the CD4 + CD25 + T cells was ascertained by flow cytometry analysis using specific antibodies labeled with phycoerythrin or FITC, and found to be 495%.
The 24-well flat-bottom plates were coated with 5 mg ml À1 anti-mouse CD3e MoAb for 2 h at room temperature. After washing, 1 Â 10 5 CD4 + CD25 + T cells were plated in coated 24-well flat-bottom in a final volume of 2 ml of complete RPMI medium (RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, 2 Â 10 À5 M 2-mercaptoethanol, 100 IU ml À1 penicillin and 100 mg ml À1 streptomycin) in the presence of 2 mg ml À1 anti-mouse CD3e MoAb and 20 ng ml À1 IL-2, with 4 Â 10 5 irradiated (15 Gy) syngeneic splenocytes as feeder cells that had been deleted of T cells by negative selection using a mouse Pan T cell isolation kit (Miltanyi Biotec). The medium was changed, anti-mouse CD3e MoAb and IL-2 were added every 3-4 days and fresh feeder cells were added every 7 days.
Construction of mouse CXCR3 or Foxp3 gene expression retroviral vectors and production of recombinant retrovirus
The pMXs-IG and pMXs-IR retroviral vectors were kindly provided by Prof. T Kitamura, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
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The pMXs-IG and pMXs-IR retroviral vectors contain GFP and DsRed, respectively. The pMXs-IG-mCXCR3 vector was used, in which the fragment containing the coding region of mouse CXCR3 gene was inserted into the SalI-NotI site of the pMXs-IG vector. The fragment containing the coding region of the mouse Foxp3 gene was inserted into the EcoRI-NotI site of the pMXs-IR vector.
The recombinant retrovirus was produced as described by Kitamura et al. 53 Briefly, 2 Â 10 6 PLAT-E cells were seeded onto 60-mm dishes 1 day before transfection using FuGENE 6 transfection reagent (Roche Diagnostics, Indianapolis, IN, USA) according to the manufacturer's protocol. Cells were cultured for 48 h and then the retroviral supernatant was stocked for infection of target cells. The estimated titers of the retroviruses were 1-3 Â 10 6 infectious units per ml based on the infected NIH3T3 cells.
Infection and expression of recombinant retroviruses
Infection and expression of recombinant retroviruses into CD4 + CD25 + T cells were performed as described by Kitamura et al. 53 First, we prepared Treg cells by infection of recombinant retrovirus carrying the pMXs-IR-Foxp3 vector into CD4 + CD25 + T cells. One million cultured CD4 + CD25 + T cells were suspended with virus stock that had been adjusted to a multiplicity of infection of 5, and then centrifuged at 1000 g for 2 h at 32 1C. These cells were then grown in complete RPMI medium in the presence of anti-CD3e MoAb and IL-2 with irradiated syngeneic splenocytes. After 2 days, Treg cells were isolated by sorting the highly expressed population. Next, CXCR3-Treg cells were isolated by FACS sorting after infection with recombinant retrovirus carrying the pMXs-IG-mCXCR3 vector into the above Treg cells as described above. The purity of both sorted Treg and CXCR3-Treg cells was 495%. After sorting, Treg and CXCR3-Treg cells were expanded in the presence of antimouse CD3e MoAb and IL-2 with irradiated syngeneic splenocytes as feeder cells as described in the section 'In Vitro Expansion of CD4 + CD25 + T Cells'. The medium was changed, anti-mouse CD3e MoAb and IL-2 were added every 3-4 days and fresh feeder cells were added every 7 days.
Total RNA preparation, cDNA synthesis and real-time PCR for chemokines, CXCR3 and Foxp3
The expressions of Th1-associated chemokines (CXCL9, CXCL10 and CXCL11), CXCR3 and Foxp3 were quantified by real-time PCR. Briefly, for qRT-PCR analysis, total RNAs were extracted from cultured cells, and snap frozen tissues using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA) as described previously. 54 The cDNA was prepared with a SuperScript III CellsDirect cDNA synthesis system (Invitrogen). The expressions of the above genes were quantified using a QuantiTect SYBR Green PCR kit (Qiagen, Valencia, CA, USA) in a 7500 Real Time PCR System (Applied Biosystems, Tokyo, Japan), and corrected with a hypoxanthine phosphoribosyl transferase 1 (HPRT1) control. Amplifications were done in a total volume of 25 ml for 45 cycles of 15 s at 95 1C and 1 min at 60 1C. Samples were run in triplicate and their relative expression was determined by normalizing the expression of each target to HPRT1 and then comparing this normalized value with the normalized expression in a reference control sample to calculate the fold change value. The primers for the amplicons spanned intron/exon boundaries to minimize any amplification of genomic DNA. The primer sequences were as follows: CXCL9, forward 
Flow cytometric analysis
The expression of Foxp3 and CXCR3 in nTreg, Treg and CXCR3-Treg cells was evaluated using PerCP-conjugated streptavidin on a FACSCalibur flow cytometer (BD Biosciences) as described previously. 9 The rat anti-mouse Foxp3 MoAb (FJK-16s) and the rat anti-mouse CXCR3 MoAb (220803) were used. For intracellular Foxp3 staining, permeabilization was performed according to the manufacturer's protocol. After reaction of these MoAbs, the cells were incubated with biotin-conjugated goat anti-rat immunoglobulin (Ig)-specific polyclonal antibody and then with PerCP-conjugated streptavidin.
Measurement of the protein levels of chemokines in the organs
Mice were killed at each time point after GVHD induction. The chest cavity was opened by sterile surgical dissection, and the inferior vena cava and abdominal aorta were clamped. Total body perfusion was performed by infusing 40 ml of phosphate-buffered saline (PBS) into the right and left ventricles by cardiac puncture to flush out the blood cells and chemokine contamination from the blood in each organ. The liver, lung and intestine (5 cm terminal ileum) were removed. Each organ was snap frozen in liquid nitrogen and stored at À80 1C until use for extraction of total RNA and measurement of the protein levels of chemokines. Frozen organs were homogenized with the same volume (w/v) of lysis buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.9; 10 mM KCl; 0.1 mM ethylenediaminetetraacetic acid; 0.1 mM ethylene glycol tetraacetic acid; 1 mM dithiothreitol; 0.5 mM phenyl methyl sulfonyl fluoride and 0.1% Nonidet NP-40) as described by Mapara et al. 17 An enzyme-linked immunosorbent assay for assaying CXCL9, CXCL10 and CXCL11 (Quantikine; R&D Systems) was performed on supernatants from the tissue homogenates according to the manufacturer's protocol.
Adoptive transfer
nTreg, Treg and CXCR3-Treg cells (4 Â 10 5 or 1 Â 10 6 cells) were transferred through tail vein into recipient mice 7 days after BMT. To examine the pathological alterations, the mice were killed 5 weeks post-BMT.
To examine the kinetics of Treg or CXCR3-Treg cells remaining in the liver, intestine and lung, these organs were harvested at 24 h, 7 days and 28 days after injection.
Preparation of mononuclear cells from the organs
Mice were killed at each time point after injection of Treg cells and CXCR3-Treg cells. Total body perfusion was carried out with PBS as described in the section 'Measurement of the Protein Levels of Chemokines in the Organs'. The liver, lung and intestine (5 cm terminal ileum) were removed. Half of each organ was snap frozen in liquid nitrogen, and stored at À80 1C for extraction of total RNA. The remaining half of each organ was cut into small pieces and placed in RPMI1640 medium containing 5% FCS, 1 mg ml À1 collagenase (Sigma-Aldrich, St Louis, MO, USA), and 100 unit per ml DNase (Takara Shuzo, Kyoto, Japan). After 30 min of collagenase digestion in a 37 1C water bath, these tissues were homogenated completely by repeated aspiration through an 18-gauge needle. The collagenase-digested tissues were then subjected to Ficoll centrifugation. The interface between the medium and the Ficoll was removed and washed twice with RPMI1640 medium containing 5% FCS. The CXCR3-Treg cells contain GFP and DsRed, while Treg cells contain only DsRed. Analysis of mouse CD8 + T cells was performed with FITC-conjugated rat anti-mouse CD8a MoAb. The fluorescent cells were examined on an Olympus IX70 inverted microscope (Olympus, Tokyo, Japan).
Chemotactic assay and in vitro suppression assay
Chemotactic assays for cultured Treg cells and CXCR3-Treg cells to CXCL10 were performed in polycarbonatemembrane, 6.5-mm diameter, 5-mm pore size transwell cell culture chambers (Costar Corp., Cambridge, MA, USA), as described previously. 9, 55 We performed in vitro suppression assay for regulatory T cells. Conventional CD4 + CD25 À T cells were purified from spleen cells of C57BL/6 mice by negative selection using a CD4 + CD25 + regulatory T cell isolation kit. Briefly, to test the suppressive action of conventional CD4 
Statistical analysis
Statistical analysis was performed using Student's t-test.
